- Trump Reciprocal Tariffs: Indian Pharma shares may see positive reaction on tariff exemption for now CNBC TV18
- Tariffs will ‘drastically’ impact global pharmaceutical supply BBC
- Industry prefers to read ‘liberation day’ measures as starting line for talks with US financialexpress.com
- US Tariffs on Pharma: Zydus, Dr Reddy’s at highest risk, says Jefferies; Check impact on other Indian pharma stocks Mint
- Domestic pharma sector on edge as US tariffs loom Times of India
Trump Reciprocal Tariffs: Indian Pharma shares may see positive reaction on tariff exemption for now CNBC TV18Tariffs will ‘drastically’ impact global pharmaceutical supply BBCIndustry prefers to read ‘liberation day’ measures as starting line for talks with US financialexpress.comUS Tariffs on Pharma: Zydus, Dr Reddy’s at highest risk, says Jefferies; Check impact on other Indian pharma stocks MintDomestic pharma sector on edge as US tariffs loom Times of India Top stories – Google News